Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2005
08/31/2005CN1660196A Extractive of Chinese traditional medicine prepared from epimedium and drynaria, and method for producing preparation
08/31/2005CN1660192A Medication for quick setting a broken bone
08/31/2005CN1660190A 'Qili' capsule for treating wound and preparation method
08/31/2005CN1660185A Preparation of soft capsule of Chinese traditional medicine for treating rheumatism and preparation method
08/31/2005CN1660179A Chinese traditional medicine for treating fracture of senior citizens
08/31/2005CN1660167A Effective part of astragalus, preparing method and application in pharmacy
08/31/2005CN1660161A Combination of Chinese traditional medicine for treating rheumatism, and preparation method and application
08/31/2005CN1660152A Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone
08/31/2005CN1660138A Natural medicine for treating osteopathia high blood pressure and diabetes etc. dozens of diseases
08/31/2005CN1660121A Paste agent of penetrating through skin for treating arthritid and preparation method
08/31/2005CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
08/31/2005CN1660051A Method for preparing bath powder of Tibet medicine and its quality control method
08/31/2005CN1216913C Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line
08/31/2005CN1216878C Process for poreparing genistein, medicinal composition and use thereof
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/31/2005CN1216857C Aniline-derived ligands for thyroid receptor
08/31/2005CN1216631C Blood quickening statis transforming plaster
08/31/2005CN1216622C Ointment for intervertebral disc
08/31/2005CN1216617C Medicine for curing aseptic necrosis of head of femur
08/31/2005CN1216615C Plaster for treating rheumatic diseases and psoatic strain and its prepn process
08/31/2005CN1216611C Bone setting-up pill
08/31/2005CN1216610C Rheumatism treating medicine
08/30/2005US6936718 Reacting with acid mixed with solvent; salt formation
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936616 Pyrimidine matrix metalloproteinase inhibitors
08/30/2005US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936603 Treating autoimmune diseases mediated by cathepsin S
08/30/2005US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups
08/30/2005US6936468 Oligodeoxyribonucleotide having one or more NF- kappa B binding sites.
08/30/2005US6936276 For tissue regeneration, applying a multilayer biodegradable matrix of crosslinked proteins and/or polysaccharides, where each layer has porosity to accomodate living cells; bone, joint, cartilage repair
08/30/2005US6936270 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body
08/30/2005US6936258 Staphylococcus antigen and vaccine
08/30/2005US6936250 Polysaccharide encapsualted antigen
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005CA2336968C Quinoline derivatives
08/30/2005CA2202879C Calcium receptor-active compounds
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/25/2005WO2005078087A1 Antibody targeting osteoclast-associated protein
08/25/2005WO2005077959A1 Pth agonists
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077396A1 Drug for osteoporosis having inhibition effect on cancer comprising ginkgo biloba extracts as the active ingredient
08/25/2005WO2005077358A1 Drug for osteoporosis comprising kampferol as the active ingredient
08/25/2005WO2005010154A3 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
08/25/2005US20050187302 administering the selective estrogen receptor modulator ospemifene, 2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints
08/25/2005US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5)
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187197 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
08/25/2005US20050186664 Albumin fusion proteins
08/25/2005US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same
08/25/2005CA2556404A1 Nitrogenous fused heteroaromatic ring derivative
08/25/2005CA2555848A1 Antibody targeting osteoclast-associated protein
08/25/2005CA2555507A1 Use of proton pump inhibitors for the treatment of cancer conditions
08/25/2005CA2554378A1 Bicycloamide derivative
08/25/2005CA2554099A1 Glycine and/or for use in cartilage affecting conditions
08/25/2005CA2553748A1 Composition and method for use in cartilage affecting conditions
08/24/2005EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
08/24/2005EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use
08/24/2005EP1565475A1 Diazinopyrimidines
08/24/2005EP1565474A2 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
08/24/2005EP1565467A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
08/24/2005EP1565459A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use
08/24/2005EP1565183A1 Rapamycin and il-10 for the treatment of immune diseases
08/24/2005EP1360185B1 Carboline derivatives
08/24/2005EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
08/24/2005EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity
08/24/2005EP1335917B1 Condensed pyridoindole derivatives
08/24/2005EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1204426B1 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
08/24/2005EP1144394B1 1-heterocycle substituted diarylamines
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4
08/24/2005CN1659288A Method to inhibit cell growth using oligonucleotides
08/24/2005CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens
08/24/2005CN1659169A Riboflavin derivative and its preparation method and uses
08/24/2005CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments
08/24/2005CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659147A Pyridazine derivatives
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1659132A Novel ligand inhibitors of the rar receptors, process for preparing same and therapeutic/cosmetic applications thereof
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1658913A Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof
08/24/2005CN1658901A Methods for treating TWEAK-related conditions
08/24/2005CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
08/24/2005CN1658893A G-type peptides to ameliorate atherosclerosis
08/24/2005CN1658886A Hormone replacement therapy
08/24/2005CN1658885A Hormone replacement therapy
08/24/2005CN1658882A Use of orally available prostacyclin derivatives for the production of a pharmaceutical agent for treating diseases that are associated with bone marrow edemas
1 ... 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 ... 820